Table 6.
Percentage of hearts presenting LVNC in TGA according to Chin, Jenni, and Petersen (apex).
| Chin | Jenni | Petersen | |||||||
|---|---|---|---|---|---|---|---|---|---|
| CHD | % (n) | OR * (95% CI) | p-Value | % (n) | OR * (95% CI) | p-Value | % (n) | OR * (95% CI) | p-Value |
| isolated TGA | 22.2% (4/18) | - | - | 11.1% (2/18) | - | - | 5.6% (1/18) | - | - |
| TGA + ASD | 6.7% (1/15) | 0.25 (0.02–2.53) | 0.3457 | 6.7% (1/15) | 0.57 (0.05–7.0) | 1.000 | 0.0% (0/15) | 0.38 (0.01–9.94) | 1.0000 |
| TGA + ASD + VSD | 57.1% (4/7) | 4.67 (0.72–30.12) | 0.1563 | 57.1% (4/7) | 10.67 (1.30–86.98) | 0.0324 | 28.6% (2/7) | 6.8 (0.51–91.55) | 0.1796 |
| TGA + VSD | 23.1% (3/13) | 1.05 (0.19–5.77) | 1.0000 | 15.4% (2/13) | 1.46 (0.18–11.94) | 1.0000 | 0.0% (0/13) | 0.43 (0.02–11.47) | 1.0000 |
* Odds ratio (OR) versus isolated TGA.